Results 41 to 50 of about 8,530 (199)

Complete remission of pulmonary alveolar proteinosis after anti-tuberculous chemotherapy: a case report

open access: yesJournal of International Medical Research, 2022
Pulmonary alveolar proteinosis (PAP) is a rare respiratory system disorder. Patients with PAP are at risk for a wide variety of secondary infections. This current case report describes a patient with PAP complicated by tuberculosis.
Guangtao Fan   +3 more
doaj   +1 more source

Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases [PDF]

open access: yes, 2012
Interstitial lung diseases (ILDs) are heterogeneous disorders, involving a large number of conditions, the approach to which continues to pose an enormous challenge for pulmonologists.
Aidé, Miguel Abidon   +24 more
core   +3 more sources

Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung

open access: yesRespiratory Medicine Case Reports
Although pulmonary complications are frequent in patients suffering from hematological diseases, secondary pulmonary alveolar proteinosis is a very rare complication of myelofibrosis.
Antoine El Kik   +4 more
doaj   +1 more source

iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice

open access: yesStem Cell Reports, 2018
Summary: Induced pluripotent stem cell (iPSC)-derived hematopoietic cells represent a highly attractive source for cell and gene therapy. Given the longevity, plasticity, and self-renewal potential of distinct macrophage subpopulations, iPSC-derived ...
Adele Mucci   +22 more
doaj   +1 more source

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis

open access: yesNature Communications, 2021
Autoimmune pulmonary alveolar proteinosis (aPAP) is a complex lung disease caused by abnormal surfactant homeostasis. Here, the authors carry out a genome-wide association study of aPAP in a Japanese cohort, finding variants in the MHC and suggesting ...
Saori Sakaue   +56 more
doaj   +1 more source

Autoimmune pulmonary alveolar proteinosis in children

open access: yesERJ Open Research, 2022
In childhood, a multitude of causes lead to pulmonary alveolar proteinosis (PAP), an excessive surfactant accumulation in the alveolar space, limiting gas exchange.
Matthias Griese   +20 more
doaj   +1 more source

Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis [PDF]

open access: yes, 2012
Rationale Pulmonary Alveolar Proteinosis (PAP) patients exhibit an acquired deficiency of biologically active granulocyte-macrophage colony stimulating factor (GM-CSF) attributable to GM-CSF specific autoantibodies. PAP alveolar macrophages are foamy,
Barna, Barbara P   +7 more
core   +3 more sources

Pulmonary Alveolar Proteinosis Syndrome [PDF]

open access: yesClinics in Chest Medicine, 2016
Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by the accumulation of surfactant in alveoli and terminal airways resulting in respiratory failure. PAP comprises part of a spectrum of disorders of surfactant homeostasis (clearance and production).
Takuji, Suzuki, Bruce C, Trapnell
openaire   +2 more sources

Assessment of Surfactant Protein A (SP-A) dependent agglutination [PDF]

open access: yes, 2010
Background: Monomers of the collectin surfactant associated protein-A (SP-A) are arranged in trimers and higher oligomers. The state of oligomerization differs between individuals and likely affects SP-A's functional properties.
Stefanie M Heinrich, Matthias Griese
core   +3 more sources

Expert‐Designed Fact Sheets and AI‐Based Analysis of Patient Symptoms to Combat Diagnostic Delays in Inherited Metabolic Diseases

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT The importance of early diagnosis of inherited metabolic diseases (IMDs) is well known, as it allows early intervention to prevent or reduce complications and improve prognosis, since many of these disorders are treatable. However, diagnosis can still be delayed, and many patients remain undiagnosed. Reducing diagnosis delays is a primary goal
Aline Cano   +108 more
wiley   +1 more source

Home - About - Disclaimer - Privacy